BEN-MAIMON CAROLE 4
4 · Larimar Therapeutics, Inc. · Filed Sep 30, 2020
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2020-09-29+411,400→ 411,400 totalExercise: $11.90Exp: 2030-07-16→ Common Stock (411,400 underlying)
Footnotes (1)
- [F1]The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The Option vests 25% on July 16, 2021, with the remaining 75% vesting in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.